Initial Use Experience of Durvalumab Plus Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer in a Japanese Territory Center.
Shionoya K, Sofuni A, Mukai S, Yamauchi Y, Tsuchiya T, Tanaka R, Tonozuka R, Yamamoto K, Nagai K, Matsunami Y, Kojima H, Minami H, Hirakawa N, Zhan Q, Itoi T.
Shionoya K, et al. Among authors: zhan q.
Cancers (Basel). 2025 Jan 19;17(2):314. doi: 10.3390/cancers17020314.
Cancers (Basel). 2025.
PMID: 39858096
Free article.